Global biosimilars sector hits US$22.58 billion in 2024, targeting US$171.79 billion by 2033 at 25.5% CAGR. Uncover trends in recombinant hormones and erythropoietin, Europe and Asia-Pacific growth, and regulatory support driving access to affordable biologics. https://finance.yahoo.com/news/biosimilars-market-surpass-us-171-141500245.html